Immunotherapy is a new hope against many forms of
cancer, now also against aggressive prostate cancer. A new drug,
called enoblituzumab, has been successfully tested in a phase 2
study.
Contact: info@neat-news.com.
neat-news.com is not responsible for the content of external sites.
We do not link to external sites in return for money or any other benefits.
The page is maintained in Germany and for any legal matters the laws of Germany apply.
Any warranty or liability is excluded in the widest legally possible sense.